PharmEasy aims to raise Rs 3,500 Cr via right issue, faces valuation slash

  • API Holdings Limited, owner of PharmEasy, leans on existing investors to raise Rs 3,500 Cr due to market challenges.
  • This financing round, including potential investment of Rs 1,200 Cr from Ranjan Pai’s family office, will repay a Goldman Sachs term loan.
  • PharmEasy valuation sinks by almost 50%, expected to reach around $500 million pre-money in the new round.
Join 2 million subscribers

A curated newsletter that summarizes the important news at the intersection of Global tech, India Tech and AI.

Delivered 8 AM. Daily.
nextbigwhat We would like to show you notifications for the latest news and updates.
Allow Notifications